These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8237797)

  • 41. Luminal narrowing after percutaneous transluminal coronary angioplasty. A multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin.
    Melkert R; Violaris AG; Serruys PW
    J Invasive Cardiol; 1994 Jun; 6(5):160-71. PubMed ID: 10155065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results of percutaneous transluminal coronary angioplasty of either the left anterior descending or left circumflex coronary artery in patients with chronic total occlusion of the right coronary artery.
    Buffet P; Danchin N; Marc MO; Feldmann L; Juilliere Y; Anconina J; Selton-Suty C; Marie PY; Cherrier F
    Am J Cardiol; 1993 Feb; 71(5):382-5. PubMed ID: 8430623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty.
    Hearn JA; Donohue BC; Ba'albaki H; Douglas JS; King SB; Lembo NJ; Roubin GS; Sgoutas DS
    Am J Cardiol; 1992 Mar; 69(8):736-9. PubMed ID: 1532112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Restenosis after percutaneous transluminal coronary angioplasty--a histopathological study using autopsied hearts.
    Morimoto S; Mizuno Y; Hiramitsu S; Yamada K; Kubo N; Nomura M; Yamaguchi T; Kitazume H; Kodama K; Kurogane H
    Jpn Circ J; 1990 Jan; 54(1):43-56. PubMed ID: 2332932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
    Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
    Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures.
    Landzberg BR; Frishman WH; Lerrick K
    Prog Cardiovasc Dis; 1997; 39(4):361-98. PubMed ID: 9050821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group.
    Pepine CJ; Hirshfeld JW; Macdonald RG; Henderson MA; Bass TA; Goldberg S; Savage MP; Vetrovec G; Cowley M; Taussig AS
    Circulation; 1990 Jun; 81(6):1753-61. PubMed ID: 2188753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty.
    Samani NJ; Martin DS; Brack M; Cullen J; Chauhan A; Lodwick D; Harley A; Swales JD; de Bono DP; Gershlick AH
    Lancet; 1995 Apr; 345(8956):1013-6. PubMed ID: 7723497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of outcome after stenting for de novo versus restenotic narrowings in native coronary arteries.
    Mittal S; Weiss DL; Hirshfeld JW; Kolansky DM; Herrmann HC
    Am J Cardiol; 1997 Sep; 80(6):711-5. PubMed ID: 9315574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.
    Holmes DR; Vlietstra RE; Smith HC; Vetrovec GW; Kent KM; Cowley MJ; Faxon DP; Gruentzig AR; Kelsey SF; Detre KM
    Am J Cardiol; 1984 Jun; 53(12):77C-81C. PubMed ID: 6233894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven.
    Dens JA; Desmet WJ; Coussement P; De Scheerder IK; Kostopoulos K; Kerdsinchai P; Supanantaroek C; Piessens JH
    Am J Cardiol; 2001 Jan; 87(1):28-33. PubMed ID: 11137829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Stents for treatment of transluminal percutaneous coronary angioplasty (PTCA) complications].
    Pieniazek P; Przewłocki T; Zmudka K; Tracz W; Dudek D; Pietrzak I; Bryniarski L; Sadowski J; Kapelak B; Drwiła R
    Przegl Lek; 1998; 55(7-8):373-7. PubMed ID: 10021879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.
    Erbel R; Haude M; Höpp HW; Franzen D; Rupprecht HJ; Heublein B; Fischer K; de Jaegere P; Serruys P; Rutsch W; Probst P
    N Engl J Med; 1998 Dec; 339(23):1672-8. PubMed ID: 9834304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multivessel PTCA using the hugging balloon technique based on single guide catheter and dual balloon-on-a-wire systems.
    Yoshida S; Yabe Y; Nakano H; Muramatsu T; Noike H
    Cathet Cardiovasc Diagn; 1991 May; 23(1):37-41. PubMed ID: 1863960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Restenosis after percutaneous transluminal coronary angioplasty--anatomic and pathophysiological mechanisms. Strategies for prevention.
    Block PC
    Circulation; 1990 Mar; 81(3 Suppl):IV2-4. PubMed ID: 2407372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty.
    Cipollone F; Marini M; Fazia M; Pini B; Iezzi A; Reale M; Paloscia L; Materazzo G; D'Annunzio E; Conti P; Chiarelli F; Cuccurullo F; Mezzetti A
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):327-34. PubMed ID: 11231910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness of tomographic thallium-201 imaging for detection of restenosis after percutaneous transluminal coronary angioplasty.
    Hecht HS; Shaw RE; Bruce TR; Ryan C; Stertzer SH; Myler RK
    Am J Cardiol; 1990 Dec; 66(19):1314-8. PubMed ID: 2244560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience.
    Guiteras Val P; Bourassa MG; David PR; Bonan R; Crépeau J; Dyrda I; Lespérance J
    Am J Cardiol; 1987 Jul; 60(3):50B-55B. PubMed ID: 2956844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EPA in the prevention of restenosis post PTCA.
    Bowles MH; Klonis D; Plavac TG; Gonzales B; Francisco DA; Roberts RW; Boxberger GR; Poliner LR; Galichia JP
    Angiology; 1991 Mar; 42(3):187-94. PubMed ID: 2018239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.